HBM's (HKG:2142) chief executive officer and chairman, Jingsong Wang, bought an additional 400,000 shares in the company from the open market at HK$3.5 apiece on Jan. 27, a Jan. 28 Hong Kong bourse filing stated.
The shares represent roughly 0.052% of the drugmaker's issued share capital.
Following the purchase, Wang holds 70,297,400, or 9.212%, shares in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.